Recent European Commission (Commission) proposals, including a broadening of the so-called ‘Bolar exemption’, would substantially change various incentive schemes related to medicinal product approvals, with the stated goal...more
As the spread of COVID-19 accelerates across the globe, everyone wants to find a way to tackle the pandemic, from Governments asking manufacturers to urgently make vital equipment to inventors creating innovative solutions. ...more
The UK government’s draft EU Withdrawal Bill (the “Brexit Bill“) aims to incorporate EU directives and regulations into UK domestic law in their current form immediately following Brexit (“Retained EU Law“). This article...more
11/15/2017
/ Biotechnology ,
EU ,
European Patent Convention ,
Intellectual Property Protection ,
Inventions ,
Member State ,
Patent Exhaustion ,
Patents ,
Pending Legislation ,
Pharmaceutical Industry ,
Referendums ,
Regulatory Oversight ,
Supplementary Protection Certificate ,
UK ,
UK Brexit ,
Unified Patent Court ,
Unitary Patent